About Us

International Symposium on Fetal Anomalies: Basics & Beyond was held in London (United Kingdom) at the Royal College of Obstetricians and Gynaecologists (RCOG) on 9 and 10 September 2023. The symposium was attended by the employees of FHRG: Iryna Feskova, Oleksandra Zozulina, Anna Feskova. Our speakers successfully shared their practical experience with other specialists in the field of prenatal diagnostics, fetal medicine and genetics. Participants shared the latest advances in the detection and treatment of fetal abnormalities, including new imaging techniques (3D/4D ultrasound, fetal MRI), genetic tests (NIPT, exome sequencing). They discussed various clinical cases, analyzed real cases of fetal anomalies, and considered some diagnostic and therapeutic strategies. During the breaks and after the sessions, participants discussed promising areas such as the use of artificial intelligence for data analysis, development of non-invasive diagnostic and therapeutic methods, as well as options for scientific and practical collaboration.

The 10th World Congress on Controversies in Preconception, Preimplantation and Prenatal Genetic Diagnosis COGEN, which took place from 3 to 4 November 2023, was attended by FHRG employees: Oleksander Feskov, Yevheniia Zhylkova, Anna Ivanova and Iryna Bezpechnaya. A presentation on the issues of preimplantation and PGD was made, the latest research and controversial issues such as the accuracy and ethics of preimplantation genetic testing (PGT) were shown. The discussions included complex case studies that addressed next-generation sequencing, counseling families at risk for hereditary diseases, and resolving diagnostic and therapeutic dilemmas, including interpreting genetic test results and making decisions under uncertainty. They also discussed the use of non-invasive prenatal testing (NIPT) and genetic editing (CRISPR/Cas9).

During the participation, an exchange of experience with colleagues took place, professional connections were established and joint projects were discussed.

Oleksandr M. Feskov took part in the busy program of the 39th Annual Meeting of ESHRE, which took place in Copenhagen, Denmark, from 25 to 28 June 2023. The meeting was traditionally devoted to the exchange of knowledge and experience in the field of reproductive medicine. The speeches of leading experts touched on the latest research in the field of IVF, genetics, endocrinology, male and female infertility, as well as innovative technologies such as CRISPR or PGT-A (preimplantation genetic testing). Also some current problems such as the use of donor reproductive materials, genome editing, selection methods, as well as issues of ART regulation in different countries were discussed. A.M. Feskov’s speech was a success, which was evidenced by the certificate issued by the organizing committee of the ESHRE meeting.

The team of authors from Professor Feskov's clinic presented their work "Application of intratesticular injection of autologous platelet rich plasma (PRP) in men with severe spermatogenesis failures" at the 10th International Congress IVIRMA, which took place from 20 to 22 April, 2023 in Malaga, Spain. The report highlighted innovative approaches to treating male infertility. The main focus was on the PRP therapy method, which involves the use of the patient's own platelet-rich plasma to stimulate tissue regeneration and improve spermatogenesis..

The work by O.M. Feskov, Yevheniya Zhylkova, Anna Ivanova, Olena Blazhko and Olexandra Zozulina presented the results of clinical studies and demonstrated the effectiveness of PRP administration in patients with severe forms of sperm production disorders.

Speakers were able to discuss the mechanisms of action of PRP, including stimulation of cell growth, improvement of microcirculation and activation of stem cells in the testicles. The discussion covered safety, side effects and long-term results of the treatment. Case studies demonstrating successful restoration of fertility in patients after using PRP were also provided.

The 19th World Congress on human reproduction, which took place in Venice, Italy, from 15 to 18 March 2023, was attended by the following employees of FHRG: Anna Feskova, O.M. Feskov, Yevheniia Zhilkova, Olena Blazhko and Iryna Bezpechnaya. Speaker Anna Feskova presented the work of a group of authors, entitled "Application of peripheral blood mononuclear cells increases embryo implantation rate in patients with recurrent IVF failures (RIF)" on 17 March. The speech was warmly received by the participants of the Congress. The President of the International Academy of Human Reproduction Genazzani Andrea warmly welcomed the speaker.

Despite the presence of eminent scientists, the Congress was held in a friendly working atmosphere. The report of our participants was noted by one of the pioneers of hormonal reproductive technology Claus Diedrich, who was one of the first to use hormones to stimulate the ovaries.

Participants received certificates of compliance from the Congress Organizing Committee.

The 38th Annual Meeting of the ESHRE was held in Milan, Italy, from 3 to 6 July 2022. Employees of Feskov human reproduction group also took part in this international meeting. The clinic was represented by Olexander M. Feskov and Iryna A. Feskova.

The meeting featured reports on the latest reproductive technologies as well as the latest achievements in the field of fertility control. This meeting helped both popularize Ukrainian school of assisted reproductive technologies and ensured an exchange of experience between leading scientists from around the world. The famous name of Feskov was once again heard and strengthened the pride of domestic medicine.

The Feskov Human Reproduction Group team visited the Kinderwunsch Tage exhibition, which was held on March 7 and 8 in Berlin. This exhibition was dedicated to surrogacy, IVF and all kinds of solutions to the reproductive problems of men and women of any complexity.

Our team presented its stand at which exhibition guests were able to get acquainted with us and our services. They could also personally talk to the Chief of the Feskov Human Reproduction Group Vladislav Feskov and the Team leader of the egg donation department Daria Feskov. Vladislav Feskov successfully made a presentation on topic “The medical and legal basis of human genomics in modern surrogate motherhood programs” and gladly answered all the questions of the Kinderwunsch Tage guests.

During these 2 busy days, we met great couples and our coordinators, Irina and Inessa, held consultations about the services of the Feskov Human Reproduction Group.

We invite all couples to a personal consultation with the managers, this will be possible in Paris, Sept 5 and 6, 2020. We are ready to answer your questions, give recommendations and dispel doubts regarding surrogacy.

May 5-8, 2016 in Copenhagen, the annual Alpha conference was held. It traditionally gathered the world's best specialists in the field of embryology and genetics.

From the Feskov human reproduction group, the embryologist-geneticist, Evgenia Stanislavovna Zhilkova, the head of the genetics laboratory, took part in the conference. She told about our achievements in embryo biopsy and about biopsy technique. In Europe, embryo biopsy is prohibited, and similar techniques are not applied. We do embryo biopsy within the limits of some reproductive programs; it is performed at a high level which is provided due to good applied base.

European colleagues appreciated our achievements in the field of embryology, and everyone gave standing ovation for our program on gender choice, about which Evgenia Zhilkova told.

The conference allowed us to share our experience with colleagues, brought new contacts and opportunities for cooperation.

April 7, 2017 in Kiev the 9^th scientific-practical conference of Ukrainian Club of Embryologists (UCE) together with international participation of “CLINICAL EMBRYOLOGY IN UKRAINE – WAYS OF OVERCOMING THE OBSTACLES” was held. The specialists of Feskov human reproduction group took active part in the event.

The ways of improving effectiveness of the IVF laboratory work, improving results monitoring as well as the conditions of embryo cultivation were discussed during the conference.

The international experience on development of competence and certification of clinical embryologists were discussed, the expediency principle in IVF laboratory design and more were reviewed.

In Feskov human reproduction group a wide range of reproductive technologies such as IVF, egg donation, surrogacy are used and thus embryology issues are of primary importance. Staff members of Feskov human reproduction group participated in the interactive session which took place in the context of the conference and were giving their presentations.

The conference resulted in interesting cooperation with colleagues and obtaining new contacts as well as contributed to exchange of experience and raising public awareness in respect of the clinic work.

July 2-5, 2017 the International Congress ESНRE 2017 was held in which collaborators of Feskov human reproduction group participated.

The leading IVF specialists and embryologists from Europe gathered to discuss new scientific elaborations in the field of reproductive medicine.

On that occasion new strategies in the area of reproductive technologies were discussed, in particular that concerns individual approach to ovarian stimulation, determining the dose of FSH and LH, peculiarities in preparation of endometrium and embryos for implantation.

Special attention was drawn to the discussion of new environments for cultivating embryos, application of embryonic stem cells for improving the quality of gametes and embryos as well as to specificities of cultivating embryos in low (5-2%) oxygen conditions. The method of pre-implantation diagnosis of embryos and the possibility of joint application of time-lapse monitoring technology and PGD were discussed. Likewise, there were other presentations devoted to reproductive medicine and embryology.

Staff members of Feskov human reproduction group, Somova Е.V., Feskov V.А., Zhilkova Е.S., Tischenko А.А. and Feskov А.М., also presented their report: “The choice of the best embryo originating from spermatozoa of men with severe male factor infertility: morphokinetics and next-generation sequencing (NGS) results”.

Feskov human reproduction group applies various reproduction technologies including IVF, donation of oocytes and surrogacy. Attending the congress helped to popularize our experience in infertility treatment and acquire new information from the representatives of the leading European reproduction clinics.

July 3-6, 2016 The 32d Annual Meeting of European Society of Human Reproduction and Embryology was held in which the leading specialists of Feskov human reproduction group participated.

European Society of Human Reproduction and Embryology aims to develop reproductive biology and medicine, strengthen academic research in the field of human reproduction and embryology and popularize the results among the general public. During 4 full days experience was shared, the latest scientific researches in the field of human reproduction were discussed, new contacts were established.

An embryologist from the Feskov human reproduction group, Aleksey Tischenko, a specialist in cryopreservation of biological objects, vitrification of eggs and embryos presented his report. The report was devoted to the results of monitoring embryos and the results of the reproductive technology programs.

The Meeting of European Society of Human Reproduction and Embryology was productive and contributed to exchange of scientific information. We successfully asserted ourselves and once again our activity was recognized at the international level.